Since TGFβ downregulates activating surface molecules in NK cells, it can impair the recognition of tumour cells by NK cells and thus impede NK-mediated cytolysis and clearance of tumour cells (Fig. 2). This evidence concerns the gene TGFB1 and neoplasm.